MedTrace Logo

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin

NCT04994431 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2024-11-07

Study results available
· View outcomes & findings →

Summary

Post-Operative Urinary Retention (POUR) in Thoracic Surgery is a prospective interventional study aiming to test the hypothesis that the prophylactic use of tamsulosin prior to thoracic surgery in high risk patients leads to reduce the rates of POUR.

Conditions

  • Thoracic Diseases
  • Urinary Retention

Interventions

DRUG

Tamsulosin Hydrochloride

0.4mg orally nightly for the two days immediately prior to surgery and the morning of surgery.

Sponsors & Collaborators

  • UMass Memorial Health

    collaborator OTHER

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Feiran Lou, MD · UMass Medical School

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2023-10-04
Completion
2023-10-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994431 on ClinicalTrials.gov